...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Volume

Posted on SEDAR today was an Exempt Distribution that was reported for a Promissory Note for $313,825 CAD from Monday. Issued with it was 71,500 warrants for common shares with an exercise price of $1.88 CAD for 5 years until April 12, 2026, It involved a lender from Alberta. It was done in USD so was probably for $250,000 USD.

Share
New Message
Please login to post a reply